logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners

May 8, 2018

Life Science

Two Chinese Pharma Companies, WuXi AppTec and Ascletis Pharma, List IPOs on Asian Exchanges

May 8, 2018

Life Science

AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million

May 8, 2018

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Acquisition Vertically Integrates Hemp/Marijuana and Nutrition Business — CFN Media

May 8, 2018

Life Science

First US drug priced at more than $1 million may be on the horizon

May 7, 2018

Life Science

FDA Gives Genentech’s Tecentriq Priority Review for Triple-Combo Lung Cancer Treatment

May 7, 2018

Life Science

Varian Acquires Taiwan Distributor,美国瓦里安医疗收购台湾放射治疗设备供应厂商

Varian Acquires Taiwan Distributor

May 7, 2018

Life Science

Resverlogix Closes US$30 Million Loan

May 7, 2018

Life Science

Nanobiotix Partners With Weill Cornell Medicine on Pre-clinical Studies to Evaluate the Impact of Nbtxr3 on Cgas-sting Pathway in Mammary Cancers

May 4, 2018

Life Science

CStone announces first patient dosed with anti-CTLA-4 antibody CS1002 of a Phase I study in Australia

May 4, 2018

Life Science

Kelun Pharmaceutical’s Anti-Cancer Drug Obtains Clinical Trial Permission From FDA,中国科伦药业抗癌药物获得美国FDA临床试验许可

Kelun Pharmaceutical’s Anti-Cancer Drug Obtains Clinical Trial Permission From FDA

May 4, 2018

Life Science

Lexaria Solidifies Presence in Edibles Market with New Agreement,Lexaria的DehydraTECH™技术再展实力,续签1906品牌大麻巧克力生产

Lexaria Solidifies Presence in Edibles Market with New Agreement

May 3, 2018

Cannabis, Life Science

Casma Therapeutics Launches with $58.5 Million

May 3, 2018

Life Science

Biotech unicorn Moderna raises another $125 million in expanded Merck partnership,美国生物科技独角兽Moderna Therapeutics获默克支付的1.25亿美元资金

Biotech unicorn Moderna raises another $125 million in expanded Merck partnership

May 3, 2018

Life Science

Chinese Drug Firm Nhwa Obtains License for Trevena Post-Operation Pain Treatment

May 3, 2018

Life Science

Maple Leaf Green World Inc TSXV:MGW Agriculture, Biotechnology, Consumer Products and Services, Cannabis, 农业,生物科技,消费品,大麻

Maple Leaf Green World Inc. Engages Emerging Equity Inc. to Raise $20 Million Private Placement

May 3, 2018

Life Science

Life Science and Tech News Weekly - www.nai500.com

Life Science & Technology Weekly 141 – Refuge Biotechnologies Raises $25 Million With Support from Chinese Investors

May 3, 2018

Life Science, Technology

CVS beats on higher prescription drug sales, shares up 4 percent,美国CVS Health第一财季盈利好于预期,股价上涨4.3%

CVS beats on higher prescription drug sales, shares up 4 percent

May 2, 2018

Life Science

  • ‹‹ Previous
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada